Literature DB >> 6661357

Release of LPL activity after intravenous injection of a low molecular weight heparin.

J Etienne, F Millot, R Pieron, P Laruelle.   

Abstract

A low molecular weight heparin (MW 4000-6000), PK 10169 (Pharmuka), with much reduced anticoagulant in vitro capacity, retains the properties of the standard heparin in releasing lipoprotein lipase and hepatic lipase activity after being injected intravenously.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6661357      PMCID： PMC1428365          DOI： 10.1111/j.1365-2125.1983.tb02246.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  9 in total

1.  A stable, radioactive substrate emulsion for assay of lipoprotein lipase.

Authors:  P Nilsson-Ehle; M C Schotz
Journal:  J Lipid Res       Date:  1976-09       Impact factor: 5.922

Review 2.  A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins.

Authors:  D B Zilversmit
Journal:  Circ Res       Date:  1973-12       Impact factor: 17.367

3.  Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma.

Authors:  J C LaRosa; R I Levy; H G Windmueller; D S Fredrickson
Journal:  J Lipid Res       Date:  1972-05       Impact factor: 5.922

4.  Evidence for an ionic binding of lipoprotein lipase to heparin.

Authors:  T Olivecrona; T Egelrud; P H Iverius; U Lindahl
Journal:  Biochem Biophys Res Commun       Date:  1971-05-07       Impact factor: 3.575

5.  [Effect of a low molecular weight heparin derivative on the release of lipolytic activity in the blood].

Authors:  F Millot; J Etienne; M Aiach; D Meyniel; D Brault; R Piéron; P Laruelle
Journal:  C R Seances Acad Sci III       Date:  1982-12-20

6.  Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism.

Authors:  J K Huttunen; C Ehnholm; M Kekki; E A Nikkilä
Journal:  Clin Sci Mol Med       Date:  1976-04

7.  Atherogenesis: a postprandial phenomenon.

Authors:  D B Zilversmit
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

8.  Binding of lipoprotein lipase to the cell surface is essential for the transmembrane transport of chylomicron cholesteryl ester.

Authors:  T Chajek-Shaul; G Friedman; O Stein; T Olivecrona; Y Stein
Journal:  Biochim Biophys Acta       Date:  1982-07-20

9.  Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.

Authors:  H Greten; R DeGrella; G Klose; W Rascher; J L de Gennes; E Gjone
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922
  9 in total
  2 in total

Review 1.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

2.  Low-Mr heparin is as potent as conventional heparin in releasing lipoprotein lipase, but is less effective in preventing hepatic clearance of the enzyme.

Authors:  G Q Liu; G Bengtsson-Olivecrona; P Ostergaard; T Olivecrona
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.